MIME-Version: 1.0
Date: Tue, 28 Sep 2021 09:23:48 +0000
References: <CACNgykOiH7sZDdjqw5HX5rHpHfQDJPpc=LJxswbv0wi92MDFBg@mail.gmail.com>
	<CAJNeY2x50KLZtcbxYyu0CVEBPmsUjB+KKnZdFhw_tAuqWeOQVg@mail.gmail.com>
	<CACNgykN+GEB0ZAeDMnOkFv9=Gwc5qvVAvN8x9fDYaOKQU-HUTA@mail.gmail.com>
	<CAJNeY2xsaZAW0Rfyc3QfyvUTGCmopop_te+yot93SiiaujVgWQ@mail.gmail.com>
In-Reply-To: <CAJNeY2xsaZAW0Rfyc3QfyvUTGCmopop_te+yot93SiiaujVgWQ@mail.gmail.com>
Message-ID: <CACNgykMJd9czMz6Y6yVji4NbdGx4cVnbbwFPWS0TcWZv3tnWzw@mail.gmail.com>
Subject: Re: Decode
From: Josh Klein <josh@josh.is>
To: Bala Kamallakharan <bala@startupiceland.com>
Content-Type: multipart/alternative; boundary="0000000000007c3a2c05cd0ac5ca"

--0000000000007c3a2c05cd0ac5ca
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Sounds interesting, but isn't this proposal orthogonal to their app-based
approach? My impression was that DeCode's genetic database and larger size
would make an easier pitch to J&J. I'll reach out to Silla to reconnect
regardless (especially if they're looking at other risk vectors now) but
would be curious if you think it's also worth connecting with DeCode.


=E1=90=A7

On Mon, Sep 27, 2021 at 3:00 PM Bala Kamallakharan <bala@startupiceland.com=
>
wrote:

> Not sure if Decode will engage, have you tried contacting Silla with
> Retina Risk? They have data and are doing more Risk Algorithms for a numb=
er
> of other risks like Heart Disease, Kidney disease etc
>
> On Mon, Sep 27, 2021 at 2:49 PM Josh Klein <josh@josh.is> wrote:
>
>> Fantastic news about Fund II; really interested to hear your posits on
>> that particular market!!
>>
>> Reg. the CGM project, I've attached the overview deck. The interest in
>> Iceland is given it's meteoric rise in diabetes, fast-follower culture,
>> high medical adherence, and strong genetic data store.
>>
>> TL;DR: A scaled Bayesian filtering process* can isolate the most
>> effective UX for behavior change... rather than starting with the data a=
nd
>> trying to convince the consumer to care about it directly. Success would
>> mean an instant new market for an existing product to improve health
>> outcomes for heart disease, obesity, and diabetes, as well as a new
>> methodology for quickly isolating effective new product designs pre-mark=
et.
>>
>> Let me know if that makes any sense!
>>
>> All best,
>> Josh
>>
>> * Using the different data types presented through different interface
>> designs in different timescales in different orders.
>> =E1=90=A7
>>
>> On Mon, Sep 27, 2021 at 11:40 AM Bala Kamallakharan <
>> bala@startupiceland.com> wrote:
>>
>>> Hi Josh,
>>>
>>> Nice to hear from you. Yes, I know some people but who is the right one
>>> to talk to about this? If you give me some specifics then it is easier =
to
>>> navigate.
>>>
>>> All good with Iceland Venture Studio and I am done with Fund I and now
>>> starting Fund II focused on India with the same investment thesis.
>>>
>>> Regards
>>> Bala
>>>
>>> On Mon, Sep 27, 2021 at 11:22 AM Josh Klein <josh@josh.is> wrote:
>>>
>>>> Bala,
>>>>
>>>> I've been working on a CGM test protocol proposal and am speaking to
>>>> some senior executives at Novo Nordisk and J&J. I'd like to propose Ic=
eland
>>>> as a potential test case and potentially partner with DeCode to run th=
e
>>>> logistics. Do you have any contacts there?
>>>>
>>>> Otherwise how are you? It's an interesting time in the investment
>>>> community! Let me know if I can be of any help.
>>>>
>>>> All best,
>>>> Josh
>>>> =E1=90=A7
>>>>
>>>
>>>
>>> --
>>> Bala Kamallakharan
>>> Founder
>>> Startup Iceland
>>> Twitter: @BalaInIceland @startupiceland
>>> <https://twitter.com/#!/startupiceland>
>>> Facebook: http://facebook.com/startupiceland
>>> Blog: http://startupiceland.com/blog
>>> Conference: http://startupiceland.com
>>>
>>
>
> --
> Bala Kamallakharan
> Founder
> Startup Iceland
> Twitter: @BalaInIceland @startupiceland
> <https://twitter.com/#!/startupiceland>
> Facebook: http://facebook.com/startupiceland
> Blog: http://startupiceland.com/blog
> Conference: http://startupiceland.com
>

--0000000000007c3a2c05cd0ac5ca
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Sounds interesting, but isn&#39;t this proposal orthogonal=
=C2=A0to their app-based approach? My impression was that DeCode&#39;s=C2=
=A0genetic database and larger size would make an easier pitch to J&amp;J. =
I&#39;ll reach out to Silla to reconnect regardless (especially if they&#39=
;re looking at other risk vectors now) but would be curious if you think it=
&#39;s also worth connecting with DeCode.<div><br></div><div><br></div></di=
v><div hspace=3D"streak-pt-mark" style=3D"max-height:1px"><img alt=3D"" sty=
le=3D"width:0px;max-height:0px;overflow:hidden" src=3D"https://mailfoogae.a=
ppspot.com/t?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocontent&amp;guid=3D7=
fddc322-457b-4919-8a44-bef2329c198d"><font color=3D"#ffffff" size=3D"1">=E1=
=90=A7</font></div><br><div class=3D"gmail_quote"><div dir=3D"ltr" class=3D=
"gmail_attr">On Mon, Sep 27, 2021 at 3:00 PM Bala Kamallakharan &lt;<a href=
=3D"mailto:bala@startupiceland.com">bala@startupiceland.com</a>&gt; wrote:<=
br></div><blockquote class=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8e=
x;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div dir=3D"ltr"=
>Not sure if Decode will engage, have you tried contacting Silla with Retin=
a Risk? They have data and are doing more Risk Algorithms for a number of o=
ther risks like Heart Disease, Kidney disease etc<br></div><br><div class=
=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">On Mon, Sep 27, 2021=
 at 2:49 PM Josh Klein &lt;<a href=3D"mailto:josh@josh.is" target=3D"_blank=
">josh@josh.is</a>&gt; wrote:<br></div><blockquote class=3D"gmail_quote" st=
yle=3D"margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padd=
ing-left:1ex"><div dir=3D"ltr">Fantastic news about Fund II; really interes=
ted to hear your posits on that particular market!!<div><br></div><div>Reg.=
 the CGM project, I&#39;ve attached the overview deck. The interest in Icel=
and is given it&#39;s meteoric rise in diabetes, fast-follower culture, hig=
h medical adherence, and strong genetic data store.=C2=A0</div><div><br></d=
iv><div>TL;DR: A scaled Bayesian=C2=A0filtering process* can isolate the mo=
st effective UX for behavior change... rather=C2=A0than starting with the d=
ata and trying to convince the consumer to care about it directly. Success =
would mean an instant new market for an existing product to improve health =
outcomes for heart disease, obesity, and diabetes, as well as a new methodo=
logy for quickly isolating effective new product designs pre-market.=C2=A0<=
/div><div><br></div><div>Let me know if that makes any sense!</div><div><br=
></div><div>All best,</div><div>Josh</div><div><br></div><div>*=C2=A0Using =
the different data types presented through different interface designs in d=
ifferent timescales in different orders.</div></div><div hspace=3D"streak-p=
t-mark" style=3D"max-height:1px"><img alt=3D"" style=3D"width: 0px; max-hei=
ght: 0px; overflow: hidden;" src=3D"https://ci4.googleusercontent.com/proxy=
/i_5ibIo2L2BnAW3ssIn2qIedEYJF9hk7DPgvE6QEUfXEAF2cON5lY-C1BlgtG2XwIhy8kOekM1=
hXTmm3ONVFaMG8k8cgFEqucwsdJeT9cMOfZSS7ZprCRRK2TWrfjAbfdEJavLZRR_l8XY7vThlhy=
xceoGuS3T5nZFQgiFHuneDMj6Fl7xZY=3Ds0-d-e1-ft#https://mailfoogae.appspot.com=
/t?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocontent&amp;guid=3D179d8def-b7=
9a-405b-af35-c0dd385bd7c7"><font size=3D"1" color=3D"#ffffff">=E1=90=A7</fo=
nt></div><br><div class=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_att=
r">On Mon, Sep 27, 2021 at 11:40 AM Bala Kamallakharan &lt;<a href=3D"mailt=
o:bala@startupiceland.com" target=3D"_blank">bala@startupiceland.com</a>&gt=
; wrote:<br></div><blockquote class=3D"gmail_quote" style=3D"margin:0px 0px=
 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div di=
r=3D"ltr"><div>Hi Josh,</div><div><br></div><div>Nice to hear from you. Yes=
, I know some people but who is the right one to talk to about this? If you=
 give me some specifics then it is easier to navigate. <br></div><div><br><=
/div><div>All good with Iceland Venture Studio and I am done with Fund I an=
d now starting Fund II focused on India with the same investment thesis. <b=
r></div><div><br></div><div>Regards</div><div>Bala<br></div></div><br><div =
class=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">On Mon, Sep 27,=
 2021 at 11:22 AM Josh Klein &lt;<a href=3D"mailto:josh@josh.is" target=3D"=
_blank">josh@josh.is</a>&gt; wrote:<br></div><blockquote class=3D"gmail_quo=
te" style=3D"margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204=
);padding-left:1ex"><div dir=3D"ltr">Bala,<div><br></div><div>I&#39;ve been=
 working on a CGM test protocol proposal and am speaking to some senior exe=
cutives at Novo Nordisk and J&amp;J. I&#39;d like to propose Iceland as a p=
otential test case and potentially partner with DeCode to run the logistics=
. Do you have any contacts there?</div><div><br></div><div>Otherwise how ar=
e you? It&#39;s an interesting time=C2=A0in the investment community! Let m=
e know if I can be of any help.</div><div><br></div><div>All best,</div><di=
v>Josh</div></div><div hspace=3D"streak-pt-mark" style=3D"max-height:1px"><=
img alt=3D"" style=3D"width: 0px; max-height: 0px; overflow: hidden;" src=
=3D"https://ci4.googleusercontent.com/proxy/DaSpfmn7VJ6biTHNF6dQ5K_CnIlZCsm=
u1EORn8_GVxpF74UCiMhNMnN6c06z7FmD2HQvehER-Pz8MLF0YZg0a9BjlzH1bn--zfYXuoXQsU=
ZhBMAI2K0N5lpjN1wI1-zd3WpzZsZhhS-CtB_lEp0gli0cKOpAWkIfkOCMDN1Tz-i9JNtvRhUw=
=3Ds0-d-e1-ft#https://mailfoogae.appspot.com/t?sender=3Daam9zaEBqb3NoLmlz&a=
mp;type=3Dzerocontent&amp;guid=3Dc96325f2-19c4-4032-a9aa-980b58640684"><fon=
t size=3D"1" color=3D"#ffffff">=E1=90=A7</font></div>
</blockquote></div><br clear=3D"all"><br>-- <br><div dir=3D"ltr"><div dir=
=3D"ltr"><div><div></div><div><font face=3D"&#39;arial narrow&#39;, sans-se=
rif" color=3D"#333333">Bala Kamallakharan</font></div><div><div><font face=
=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">Founder</font></d=
iv><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333"=
>Startup Iceland</font></div><div><font face=3D"&#39;arial narrow&#39;, san=
s-serif" color=3D"#333333">Twitter: @BalaInIceland @<a href=3D"https://twit=
ter.com/#!/startupiceland" target=3D"_blank">startupiceland</a></font></div=
><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">F=
acebook: <a href=3D"http://facebook.com/startupiceland" target=3D"_blank">h=
ttp://facebook.com/startupiceland</a></font></div><div><font face=3D"&#39;a=
rial narrow&#39;, sans-serif" color=3D"#333333">Blog: <a href=3D"http://sta=
rtupiceland.com/blog" target=3D"_blank">http://startupiceland.com/blog</a><=
/font></div><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D=
"#333333">Conference: <a href=3D"http://startupiceland.com" target=3D"_blan=
k">http://startupiceland.com</a></font></div></div></div></div></div>
</blockquote></div>
</blockquote></div><br clear=3D"all"><br>-- <br><div dir=3D"ltr"><div dir=
=3D"ltr"><div><div></div><div><font face=3D"&#39;arial narrow&#39;, sans-se=
rif" color=3D"#333333">Bala Kamallakharan</font></div><div><div><font face=
=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">Founder</font></d=
iv><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333"=
>Startup Iceland</font></div><div><font face=3D"&#39;arial narrow&#39;, san=
s-serif" color=3D"#333333">Twitter: @BalaInIceland @<a href=3D"https://twit=
ter.com/#!/startupiceland" target=3D"_blank">startupiceland</a></font></div=
><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">F=
acebook: <a href=3D"http://facebook.com/startupiceland" target=3D"_blank">h=
ttp://facebook.com/startupiceland</a></font></div><div><font face=3D"&#39;a=
rial narrow&#39;, sans-serif" color=3D"#333333">Blog: <a href=3D"http://sta=
rtupiceland.com/blog" target=3D"_blank">http://startupiceland.com/blog</a><=
/font></div><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D=
"#333333">Conference: <a href=3D"http://startupiceland.com" target=3D"_blan=
k">http://startupiceland.com</a></font></div></div></div></div></div>
</blockquote></div>

--0000000000007c3a2c05cd0ac5ca--